| Product Code: ETC10692750 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India anti-infective drugs market import shipment demonstrated robust growth with a CAGR of 23.1% from 2020 to 2024. The growth rate between 2023 and 2024 was 15.7%, indicating a strong upward momentum. The market expanded significantly, showing a consistent upward trend over the years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Anti-Infective Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Anti-Infective Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Anti-Infective Drugs Market - Industry Life Cycle |
3.4 India Anti-Infective Drugs Market - Porter's Five Forces |
3.5 India Anti-Infective Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Anti-Infective Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Anti-Infective Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Anti-Infective Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in India |
4.2.2 Growing awareness about the importance of proper infection control measures |
4.2.3 Rising healthcare expenditure and government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High competition among anti-infective drug manufacturers |
4.3.2 Increasing prevalence of drug resistance leading to limited effectiveness of existing drugs |
5 India Anti-Infective Drugs Market Trends |
6 India Anti-Infective Drugs Market, By Types |
6.1 India Anti-Infective Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Anti-Infective Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Anti-Infective Drugs Market Revenues & Volume, By Antibiotics, 2021 - 2031F |
6.1.4 India Anti-Infective Drugs Market Revenues & Volume, By Antivirals, 2021 - 2031F |
6.1.5 India Anti-Infective Drugs Market Revenues & Volume, By Antifungals, 2021 - 2031F |
6.1.6 India Anti-Infective Drugs Market Revenues & Volume, By Antiprotozoals, 2021 - 2031F |
6.2 India Anti-Infective Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Anti-Infective Drugs Market Revenues & Volume, By Skin Infections, 2021 - 2031F |
6.2.3 India Anti-Infective Drugs Market Revenues & Volume, By HIV/AIDS, 2021 - 2031F |
6.2.4 India Anti-Infective Drugs Market Revenues & Volume, By Candidiasis, 2021 - 2031F |
6.2.5 India Anti-Infective Drugs Market Revenues & Volume, By Malaria, 2021 - 2031F |
6.3 India Anti-Infective Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Anti-Infective Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Anti-Infective Drugs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 India Anti-Infective Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.5 India Anti-Infective Drugs Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
7 India Anti-Infective Drugs Market Import-Export Trade Statistics |
7.1 India Anti-Infective Drugs Market Export to Major Countries |
7.2 India Anti-Infective Drugs Market Imports from Major Countries |
8 India Anti-Infective Drugs Market Key Performance Indicators |
8.1 Number of new clinical trials for anti-infective drugs in India |
8.2 Percentage of hospitals implementing infection control protocols |
8.3 Government funding towards research and development of new anti-infective drugs |
8.4 Rate of adoption of newer, more effective anti-infective drugs |
8.5 Number of reported cases of drug-resistant infections in India |
9 India Anti-Infective Drugs Market - Opportunity Assessment |
9.1 India Anti-Infective Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Anti-Infective Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Anti-Infective Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Anti-Infective Drugs Market - Competitive Landscape |
10.1 India Anti-Infective Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Anti-Infective Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here